ArticleClinical case reports2022

Successful treatment with bortezomib for refractory fever associated with myelodysplastic syndrome with underlying lymphoplasmacytic lymphoma.

Yotaro Motomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.